We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
HCA Healthcare, Inc.’s (HCA - Free Report) fourth-quarter 2020 adjusted earnings of $4.13 per share beat the Zacks Consensus Estimate by 13.8%. Further, the bottom line improved 33.7% year over year on the back of higher revenues.
The company witnessed solid inpatient volumes in the quarter.
Quarterly Details
HCA Healthcare’s revenues of $14.29 billion beat the Zacks Consensus Estimate by 2.5%. The top line also improved 5.7% from the year-ago period.
Same facility equivalent admissions declined 7.5% year over year while same facility admissions dipped 3.4% year over year. However, same facility revenue per equivalent admission grew 14.1% year over year on account of higher acuity of patients treated and a favorable payer mix witnessed in the quarter.
Same facility inpatient surgeries and same facility outpatient surgeries slid 6.7% and 5.1%, respectively, year over year.
Salaries and benefits, supplies and other operating expenses were up 3.5% year over year to $11.1 billion.
Adjusted EBITDA totaled $3.12 billion, up 13.9% year over year.
As of Dec 31, 2020, HCA Healthcare operated 185 hospitals.
HCA Healthcare, Inc. Price, Consensus and EPS Surprise
Total assets came in at $47.5 billion as of Dec 31, 2020, up 5.4% from the 2019-end level.
Total debt of nearly $31 billion as of Dec 31, 2020 decreased 8.3% from the level at 2019 end.
In the reported quarter, capex came in at $748 million minus acquisitions.
Cash flows used in operating activities were $3.58 billion compared to cash flow provided by operating activities amounting to $2.5 billion in the year-ago period.
2021 Guidance
The company issued 2021 guidance following fourth-quarter 2020 results. Management expects revenues for the current year in the band of $53.5-$55.5 billion.
Adjusted EBITDA is estimated to be $10.3-$10.9 billion.
Capex of the company came in at $3.7 billion.
EPS for the company is projected at $12.10-$13.10 per share.
Share Repurchase and Dividend Update
The company’s board of directors recently resumed its share buyback policy, pertaining to which $2.8 billion was available for repurchase before its withdrawal. The board also authorized a plan for up to an additional $6 billion of its remaining outstanding stock.
HCA Healthcare also recommenced its quarterly dividend plan. It announced a quarterly cash dividend of 48 cents per share on its common stock. The dividend is payable Mar 31, 2021 to its shareholders of record on Mar 17, 2021.
Full-Year Results
HCA Healthcare’s revenues for 2020 came in at $51.5 billion, up 0.4% year over year.
Net income attributable was $10.93 per share, increasing 8.5% year over year.
For 2020, adjusted EBITDA was $10 billion, up 1.8% year over year.
Zacks Rank & Peer Releases
HCA Healthcare currently carries a Zacks Rank #4 (Sell).
Among other players from the medical space that have reported fourth-quarter earnings so far, the bottom-line results of UnitedHealth Group Incorporated (UNH - Free Report) beat estimates while that of Anthem, Inc. missed the same.
Upcoming Q4 Release
Community Health Systems, Inc. (CYH - Free Report) has an Earnings ESP of +663.64% and a Zacks Rank #3 (Hold). The company is scheduled to release fourth-quarter 2020 earnings on Feb 17. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Zacks Names “Single Best Pick to Double”
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
You know this company from its past glory days, but few would expect that it’s poised for a monster turnaround. Fresh from a successful repositioning and flush with A-list celeb endorsements, it could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in a little more than 9 months and Nvidia which boomed +175.9% in one year.
Image: Bigstock
HCA Healthcare's (HCA) Q4 Earnings Beat Estimates, Rise Y/Y
HCA Healthcare, Inc.’s (HCA - Free Report) fourth-quarter 2020 adjusted earnings of $4.13 per share beat the Zacks Consensus Estimate by 13.8%. Further, the bottom line improved 33.7% year over year on the back of higher revenues.
The company witnessed solid inpatient volumes in the quarter.
Quarterly Details
HCA Healthcare’s revenues of $14.29 billion beat the Zacks Consensus Estimate by 2.5%. The top line also improved 5.7% from the year-ago period.
Same facility equivalent admissions declined 7.5% year over year while same facility admissions dipped 3.4% year over year. However, same facility revenue per equivalent admission grew 14.1% year over year on account of higher acuity of patients treated and a favorable payer mix witnessed in the quarter.
Same facility inpatient surgeries and same facility outpatient surgeries slid 6.7% and 5.1%, respectively, year over year.
Salaries and benefits, supplies and other operating expenses were up 3.5% year over year to $11.1 billion.
Adjusted EBITDA totaled $3.12 billion, up 13.9% year over year.
As of Dec 31, 2020, HCA Healthcare operated 185 hospitals.
HCA Healthcare, Inc. Price, Consensus and EPS Surprise
HCA Healthcare, Inc. price-consensus-eps-surprise-chart | HCA Healthcare, Inc. Quote
Financial Update
Total assets came in at $47.5 billion as of Dec 31, 2020, up 5.4% from the 2019-end level.
Total debt of nearly $31 billion as of Dec 31, 2020 decreased 8.3% from the level at 2019 end.
In the reported quarter, capex came in at $748 million minus acquisitions.
Cash flows used in operating activities were $3.58 billion compared to cash flow provided by operating activities amounting to $2.5 billion in the year-ago period.
2021 Guidance
The company issued 2021 guidance following fourth-quarter 2020 results.
Management expects revenues for the current year in the band of $53.5-$55.5 billion.
Adjusted EBITDA is estimated to be $10.3-$10.9 billion.
Capex of the company came in at $3.7 billion.
EPS for the company is projected at $12.10-$13.10 per share.
Share Repurchase and Dividend Update
The company’s board of directors recently resumed its share buyback policy, pertaining to which $2.8 billion was available for repurchase before its withdrawal. The board also authorized a plan for up to an additional $6 billion of its remaining outstanding stock.
HCA Healthcare also recommenced its quarterly dividend plan. It announced a quarterly cash dividend of 48 cents per share on its common stock. The dividend is payable Mar 31, 2021 to its shareholders of record on Mar 17, 2021.
Full-Year Results
HCA Healthcare’s revenues for 2020 came in at $51.5 billion, up 0.4% year over year.
Net income attributable was $10.93 per share, increasing 8.5% year over year.
For 2020, adjusted EBITDA was $10 billion, up 1.8% year over year.
Zacks Rank & Peer Releases
HCA Healthcare currently carries a Zacks Rank #4 (Sell).
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Among other players from the medical space that have reported fourth-quarter earnings so far, the bottom-line results of UnitedHealth Group Incorporated (UNH - Free Report) beat estimates while that of Anthem, Inc. missed the same.
Upcoming Q4 Release
Community Health Systems, Inc. (CYH - Free Report) has an Earnings ESP of +663.64% and a Zacks Rank #3 (Hold). The company is scheduled to release fourth-quarter 2020 earnings on Feb 17. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Zacks Names “Single Best Pick to Double”
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
You know this company from its past glory days, but few would expect that it’s poised for a monster turnaround. Fresh from a successful repositioning and flush with A-list celeb endorsements, it could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in a little more than 9 months and Nvidia which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>